Clinical Trial Update: Open-Label, Randomized Study Evaluating Treatment With Venlafaxine Extended-Release Plus Dialogues Time to Talk Program [Phase 4]

View source ↗

Summary

Open-label, randomized Phase 4 trial evaluating venlafaxine extended-release combined with the Dialogues Time to Talk program for major depressive disorder; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Effexor XR (venlafaxine)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Depressive Disorder, Major | Phase 4 | Status: COMPLETED | Results posted: 2010-06-29